heme has been researched along with fludrocortisone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, M; Hanaki, K; Kanzaki, S; Kawashima, Y; Miyahara, N; Nishimura, R; Usui, T | 1 |
1 other study(ies) available for heme and fludrocortisone
| Article | Year |
|---|---|
A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Amino Acid Substitution; Anti-Inflammatory Agents; Binding, Competitive; Family Health; Fludrocortisone; Heme; Heterozygote; Humans; Hydrocortisone; Infant; Male; Parents; Point Mutation; Progesterone; Steroid 21-Hydroxylase; Substrate Specificity; Treatment Outcome; Up-Regulation | 2015 |